Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

Autor: Fassnacht, Martin, Berruti, Alfredo, Baudin, Eric, Demeure, Michael J, Gilbert, Jill, Haak, Harm, Kroiss, Matthias, Quinn, David I, Hesseltine, Elizabeth, Ronchi, Cristina L, Terzolo, Massimo, Choueiri, Toni K, Poondru, Srinivasu, Fleege, Tanya, Rorig, Ramona, Chen, Jihong, Stephens, Andrew W, Worden, Francis, Hammer, Gary D
Zdroj: In The Lancet Oncology April 2015 16(4):426-435
Databáze: ScienceDirect